Q3 2024 |
14 |
$1.03B |
+$183M |
-$335M |
-$152M |
GIL, UTI, SONO, GMS, HRI
|
13F-HR |
11/14/2024, 04:20 PM |
Q2 2024 |
14 |
$1.12B |
+$128M |
-$31.8K |
+$128M |
GIL, UTI, RCM, MODV, GMS
|
13F-HR |
8/14/2024, 04:15 PM |
Q1 2024 |
11 |
$1.08B |
+$70.2M |
-$342M |
-$272M |
GIL, UTI, RCM, PRPL, SONO
|
13F-HR |
5/15/2024, 04:05 PM |
Q4 2023 |
11 |
$1.25B |
+$233M |
-$106M |
+$127M |
GIL, GMS, UTI, MODV, SONO
|
13F-HR |
2/14/2024, 04:26 PM |
Q3 2023 |
11 |
$959M |
+$127M |
-$82.2M |
+$44.7M |
GIL, GMS, MODV, SONO, PRPL
|
13F-HR |
11/14/2023, 04:22 PM |
Q2 2023 |
12 |
$1.11B |
+$126M |
-$338M |
-$212M |
GIL, GMS, PRPL, SONO, MODV
|
13F-HR |
8/14/2023, 04:51 PM |
Q1 2023 |
12 |
$1.32B |
+$171M |
-$262M |
-$90.7M |
GMS, GIL, SONO, PRPL, MODV
|
13F-HR |
5/15/2023, 04:58 PM |
Q4 2022 |
13 |
$1.34B |
+$128M |
-$180M |
-$51.6M |
GMS, BLDR, PRPL, GIL, MODV
|
13F-HR |
2/14/2023, 04:15 PM |
Q3 2022 |
13 |
$1.23B |
+$127M |
-$78.2M |
+$49.1M |
BLDR, GMS, PRPL, MODV, SONO
|
13F-HR |
11/14/2022, 04:57 PM |
Q2 2022 |
14 |
$1.13B |
+$156M |
-$2.8M |
+$153M |
BLDR, GMS, PRPL, MODV, SONO
|
13F-HR |
8/15/2022, 05:39 PM |
Q1 2022 |
13 |
$1.33B |
+$337M |
-$7.55M |
+$330M |
BLDR, GMS, PRPL, MODV, SONO
|
13F-HR |
5/16/2022, 04:13 PM |
Q4 2021 |
11 |
$1.31B |
+$269M |
-$370M |
-$100M |
BLDR, GMS, PRPL, MODV, BLBD
|
13F-HR |
2/14/2022, 04:15 PM |
Q3 2021 |
8 |
$1.13B |
+$16.9M |
-$47.2M |
-$30.3M |
BLDR, MODV, GMS, PRPL, GORV
|
13F-HR |
11/16/2021, 09:52 AM |
Q2 2021 |
7 |
$1.13B |
+$34.9M |
-$200M |
-$165M |
BLDR, MODV, GMS, PRPL, GORV
|
13F-HR |
8/16/2021, 04:41 PM |
Q1 2021 |
7 |
$1.34B |
+$711M |
-$631M |
+$80.1M |
PRPL, BLDR, MODV, GMS, GORV
|
13F-HR |
5/17/2021, 04:15 PM |
Q4 2020 |
10 |
$1.22B |
+$176M |
-$144M |
+$32.5M |
PRPL, BMCH, PRSC, GMS, FBM
|
13F-HR |
2/16/2021, 04:30 PM |
Q3 2020 |
11 |
$916M |
+$46.7M |
-$37.2M |
+$9.48M |
BMCH, PRPL, PRSC, GIL, GMS
|
13F-HR |
11/16/2020, 04:15 PM |
Q2 2020 |
13 |
$686M |
+$208M |
-$106M |
+$102M |
PRPL, BMCH, PRSC, GIL, GMS
|
13F-HR |
8/14/2020, 04:12 PM |
Q1 2020 |
18 |
$369M |
+$127M |
-$14.3M |
+$112M |
BMCH, PRSC, PRPL, LGC, CNR
|
13F-HR |
5/15/2020, 04:00 PM |
Q4 2019 |
11 |
$376M |
+$76.7M |
-$62.2M |
+$14.5M |
BMCH, PRPL, PRSC, CNR, LGC
|
13F-HR |
2/14/2020, 04:35 PM |
Q3 2019 |
14 |
$362M |
+$63.9M |
-$44.1M |
+$19.8M |
BMCH, PRSC, PRPL, BXC, CNR
|
Restatement |
2/14/2020, 04:10 PM |
Q2 2019 |
13 |
$309M |
+$30.7M |
-$4.13M |
+$26.6M |
PRSC, BMCH, PRPL, LGCU, RLH
|
13F-HR |
8/14/2019, 04:28 PM |
Q1 2019 |
13 |
$277M |
+$15.3M |
-$4.13M |
+$11.2M |
PRSC, BMCH, LGCU, RLH, PRPL
|
13F-HR |
5/15/2019, 04:30 PM |
Q4 2018 |
13 |
$268M |
+$57.6M |
-$7.04M |
+$50.6M |
PRSC, PRPL, BMCH, LGCU, RLH
|
13F-HR |
2/14/2019, 04:16 PM |
Q3 2018 |
9 |
$246M |
+$18.7M |
-$5.46M |
+$13.2M |
PRSC, RLH, PRPL, LGCU, BKD
|
13F-HR |
11/13/2018, 05:48 PM |
Q2 2018 |
9 |
$259M |
+$47.2M |
-$57.4M |
-$10.2M |
PRSC, PRPL, RLH, LGCU, BKD
|
13F-HR |
8/14/2018, 04:53 PM |
Q1 2018 |
10 |
$249M |
+$73.7M |
-$808K |
+$72.9M |
PRSC, PRPL, LGCU, LHCG, UTI
|
13F-HR |
5/15/2018, 05:03 PM |
Q4 2017 |
8 |
$157M |
+$38.5M |
-$21.5M |
+$17M |
PRSC, LGCU, UTI, ARQ, LHCG
|
13F-HR |
2/14/2018, 05:18 PM |
Q3 2017 |
5 |
$135M |
$0 |
-$37.5M |
-$37.5M |
PRSC, UTI, ARQ, BIOS, DXLG
|
13F-HR |
11/14/2017, 03:47 PM |
Q2 2017 |
8 |
$164M |
$0 |
-$74.2M |
-$74.2M |
PRSC, BIOS, UTI, BLBD, LHCG
|
13F-HR |
8/14/2017, 03:22 PM |
Q1 2017 |
10 |
$222M |
+$10.3M |
-$28.4M |
-$18.1M |
PRSC, LHCG, ASNA, ARQ, BLBD
|
13F-HR |
5/15/2017, 04:56 PM |
Q4 2016 |
7 |
$222M |
$0 |
-$53.6M |
-$53.6M |
PRSC, BLBD, LHCG, ASNA, ARQ
|
13F-HR |
2/14/2017, 05:34 PM |
Q3 2016 |
10 |
$285M |
+$30.4M |
-$392K |
+$30.1M |
PRSC, BLBD, LHCG, ASNA, ACW
|
13F-HR |
11/14/2016, 05:30 PM |
Q2 2016 |
9 |
$240M |
+$22.5M |
-$13M |
+$9.52M |
PRSC, LHCG, ASNA, BLBD, BIOS
|
13F-HR |
8/15/2016, 05:05 PM |
Q1 2016 |
11 |
$258M |
+$26M |
-$16.8M |
+$9.17M |
PRSC, ASNA, LHCG, BLBD, UTI
|
13F-HR |
5/16/2016, 04:17 PM |
Q4 2015 |
11 |
$246M |
+$25.8M |
-$17.1M |
+$8.61M |
PRSC, LHCG, BLBD, ASNA, UTI
|
13F-HR |
2/16/2016, 05:09 PM |
Q3 2015 |
8 |
$248M |
+$6M |
-$41.3M |
-$35.3M |
PRSC, LHCG, ASNA, BLBD, ACW
|
13F-HR |
11/16/2015, 04:06 PM |
Q2 2015 |
8 |
$295M |
+$9.1M |
-$53.9M |
-$44.8M |
PRSC, LHCG, ASNA, BLBD, ACW
|
13F-HR |
8/14/2015, 04:28 PM |
Q1 2015 |
8 |
$332M |
+$35.6M |
-$57M |
-$21.4M |
PRSC, LHCG, CROX, ACW, ASNA
|
13F-HR |
5/15/2015, 01:24 PM |
Q4 2014 |
9 |
$311M |
+$36.2M |
-$2.8M |
+$33.4M |
PRSC, LHCG, ARQ, CROX, ACW
|
13F-HR |
2/17/2015, 08:40 PM |
Q3 2014 |
8 |
$280M |
+$16.9M |
-$49.1M |
-$32.3M |
PRSC, LHCG, CROX, ARQ, ACW
|
13F-HR |
11/14/2014, 11:42 AM |
Q2 2014 |
10 |
$298M |
+$26.6M |
-$7.65M |
+$18.9M |
PRSC, LHCG, ACW, CROX, ARQ
|
13F-HR |
8/14/2014, 04:39 PM |
Q1 2014 |
12 |
$259M |
+$48.9M |
-$22.3M |
+$26.6M |
PRSC, LHCG, ACW, CROX, MED
|
13F-HR |
5/15/2014, 04:20 PM |
Q4 2013 |
11 |
$236M |
$0 |
$0 |
|
LHCG, PRSC, CROX, ACW, JMBA
|
13F-HR |
2/14/2014, 04:00 PM |